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Background/Aims
Functional gastrointestinal disorders (FGIDs), diagnosed by symptom-based criteria due to lack of biomarkers, need translated-
validated questionnaires in different languages. As Bengali, the mother tongue of Bangladesh and eastern India, is the seventh most 
spoken language in the world, we translated and validated the Enhanced Asian Rome III questionnaire (EAR3Q) in this language. 
Methods
The EAR3Q was translated in Bengali as per guideline from the Rome Foundation. The translated questionnaire was validated 
prospectively on Bengali-speaking healthy subjects (HS, n = 30), and patients with functional dyspepsia (FD, n = 35), irritable bowel 
syndrome (IBS, n = 40) and functional constipation (FC, n = 12) diagnosed by clinicians using the Rome III criteria. The subjects were 
asked to fill-in the questionnaire again after 2 weeks, to check for its reproducibility. 
Results
During translation, the original and the backward translated English versions of the questionnaire demonstrated high concordance. 
Sensitivity of the Bengali questionnaire to diagnose patients with FD, IBS, FC, and HS was 100%, 100%, 75%, and 100%, respectively, 
considering diagnosis by the clinicians as the gold standard. On test-retest reliability analysis, Kappa values for FD, IBS, FC, and HS 
were 1.0, 1.0, 0.83, and 1.0, respectively. The Bengali questionnaire detected considerable overlap of FD symptoms among patients 
with IBS, IBS among patients with FD, and FD among patients with FC, which were not detected by the clinicians. 
Conclusions
We successfully translated and validated the EAR3Q in Bengali. We believe that this translated questionnaire will be useful for clinical 
evaluation and research on FGIDs in the Bengali-speaking population.
(J Neurogastroenterol Motil 2016;22:240-247)
Key Words
Bangladesh; Constipation; Dyspepsia; India; Irritable bowel syndrome
Received: August 13, 2015    Revised: November 22, 2015    Accepted: November 29, 2015
  This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons. 
org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work 
is properly cited.
*Correspondence:  Uday C Ghoshal, MD, DNB, DM, FACG, RFF 
Department of Gastroenterology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow-226014, India 
Tel: +91-800-4904780, Fax: +91-522-2668017 or 2668078, E-mail: udayghoshal@gmail.com
JNM
J Neurogastroenterol Motil,  Vol. 22  No. 2   April,  2016
pISSN: 2093-0879   eISSN: 2093-0887
http://dx.doi.org/10.5056/jnm15129
Original ArticleJournal of Neurogastroenterology and Motility 
ⓒ 2016 The Korean Society of Neurogastroenterology and Motility
J Neurogastroenterol Motil, Vol. 22  No. 2   April,  2016
www.jnmjournal.org
241
Translation-validation of EAR3Q in Bengali
Vol. 22, No. 2   April, 2016 (240-247)
Introduction  
Functional gastrointestinal disorders (FGIDs) are common 
conditions in gastroenterology practice and are diagnosed currently 
by a combination of multiple symptoms, absence of alarm features, 
and organic causes explaining the symptoms on routine investiga-
tions.1 Though extensive investigations may reveal several condi-
tions such as gut dysbiosis, celiac disease, lactose malabsorption, 
food hypersensitivity, tropical sprue, or fecal evacuation disorders 
explaining symptoms in a subset of patients with FGIDs, the cur-
rent Rome III diagnostic algorithm does not warrant such testing to 
exclude these causes before making a diagnosis of FGID. To bring 
homogeneity in research, to avoid excessive investigations compli-
cating management of these patients in resource limited settings, 
and to be useful in clinical practice, the Rome Foundation devel-
oped the Rome criteria2-4 for classifications and diagnosis of FGIDs 
by consensus, which is currently in its third iteration.4 
Although the Rome criteria are widely used in research and pa-
tient care,5,6 these have limitations as these were originally developed 
in English-speaking Western populations, and may not give suf-
ficient importance to the socio-cultural issues, language, symptom 
perception, and reporting and spectrum of FGIDs in non-Western 
populations.7 Socio-cultural factors influence the illness beliefs, 
perception, and expression of gastrointestinal (GI) symptoms.8-11 
Therefore, for symptom-based diagnosis, linguistic translation of a 
questionnaire alone is quite inadequate unless cultural adaptation of 
the terminology is undertaken to imply the underlying intentions. 
Since FGIDs are diagnosed by symptoms-based criteria,1,12 and 
symptoms are influenced by psychosocial and socio-cultural fac-
tors,8-11 there has been concern whether the Rome III questionnaire 
in its original form would be similarly applicable for uniform diag-
nosis, sub-typing, and treatment allocation for FGIDs throughout 
the world.11,13 To overcome some of the above-mentioned limita-
tions, the Enhanced Asian Rome III questionnaire (EAR3Q)14 
has been developed by the Asian experts by consensus, which is a 
culturally adapted version of the Rome III diagnostic questionnaire 
(R3DQ).15 
Bengali is one of the most spoken languages and is ranked 
seventh in the world.16 It is the second most commonly spoken 
language in India and a native language to the region of Eastern 
South Asia formally known as Bengal, which comprises the present 
day Bangladesh, the Indian state of West Bengal, and parts of the 
Indian states of Tripura and Assam.17 Population based studies on 
FGIDs, done in a Bengali speaking population18-20 suggest that the 
epidemiological features of FGIDs in this region are comparable 
to most Asian studies and may differ from the West.7,18-28 However, 
these findings need to be addressed further in multi-national cross-
cultural studies.10,11 One of the barriers to such studies is the lack 
of a culturally adapted questionnaire that has been translated and 
validated in Bengali. Therefore, as an initial step towards such stud-
ies, we aimed to translate the EAR3Q into Bengali and to validate it 
in prospective samples of healthy subjects (HS), patients suffering 
from functional dyspepsia (FD), irritable bowel syndrome (IBS), 
and functional constipation (FC) to see whether the translated 
questionnaire can diagnose different FGIDs according to the Rome 
criteria. 
Materials and Methods  
The EAR3Q was translated in Bengali first. The translated 
questionnaire was tested for understandability among a group 
of HS. It was then validated in prospective samples of Bengali-
speaking patients suffering from FD, IBS, and FC diagnosed by 
the clinicians as would be done in practice and on another group of 
HS twice at 2-week intervals.
The Process of Translation
During a 9-month period (between May, 2011 and Febru-
ary, 2012) the EAR3Q was translated as per guideline from the 
Rome Foundation.29 The EAR3Q was translated into Bengali by 
2 independent translators, one of them was a gastroenterologist 
and the other an internal medicine specialist. Both were bi-lingual 
physicians, native Bengali speakers, and were fluent in English. 
The product of this step was forward version 1a and 1b in Bengali 
(Figure). In the next step, the two versions were reconciled into a 
final Bengali version (version 2) by a gastroenterologist who was 
well-conversant in Bengali and English. In the next step, an Eng-
lish teacher, who was well-conversant in Bengali and English, back 
translated this reconciled Bengali questionnaire into English. Sub-
sequently, the original and backward translated English versions 
of the questionnaire were assessed for similarities of language and 
interpretation. During this phase, revision and modification of Ben-
gali version 2 was made as needed to create Bengali version 3. The 
changes made during this phase were recorded. 
Cognitive Debriefing
Cognitive debriefing was done by testing the questionnaire 
among 10 Bengali speaking subjects with apparently normal health 
and patients with different GI symptoms. To assess the clarity of 
242
M Masudur Rahman, et al
Journal of Neurogastroenterology and Motility 
individual questions, a 10-point Likert scale was used; value of 1 
in the Likert scale indicated poor understandability and that of 10 
suggested complete understandability.
Validation of the Translated Questionnaire
The final translated questionnaire (Supplementary Table) was 
validated on subjects with FD, IBS, FC, and HS. Patients with 
FD, IBS, and FC were diagnosed by the clinicians as would be 
done in practice using the Rome III criteria by clinical interview. 
During enrollment, every subject was asked about presence of 
alarm features. Those with alarm features were adequately investi-
gated by colonoscopy, imaging, and laboratory studies as indicated, 
to exclude organic diseases before inclusion into the study. Those 
without alarm features, however, were also investigated with routine 
laboratory tests including upper GI endoscopy, colonoscopy, and 
imaging.
The HS were apparently healthy with no significant medi-
cal history. After the clinicians made the categorical diagnosis of 
FGID in the clinic, the patients and the HS were requested to fill 
in the questionnaire by themselves. A research assistant sat with the 
subjects while they filled in the questionnaire for any clarification, if 
needed, and for recording the time needed to fill up the question-
naire. The research assistant was a post-graduate trainee in gastro-
enterology. She was trained on FGIDs, specifically the EAR3Q. 
She is a native speaker of Bengali. She was involved throughout the 
study. After an interval of 2 weeks, the subjects were asked to fill in 
the questionnaire again. The protocol was approved by the Ethics 
and Review Committee of Shaheed Suhrawardy Medical College 
and Hospital, and informed consent was obtained from each sub-
ject.
Statistical Methods
The categorical and continuous data are presented as propor-
tion, median, and range, respectively. Considering the diagnosis by 
the clinician as the gold standard, the sensitivity of the questionnaire 
to pick-up the correct diagnostic category at the initial visit was as-
sessed. Specificity was calculated by estimating the proportion of 
HS considered as healthy according to the response from the ques-
tionnaire. The agreement between the diagnoses made at 2 time 
points using the questionnaire was evaluated using kappa statistics. 
Values for kappa > 0.80 were considered excellent agreement, be-
tween 0.61-0.80 as good agreement, and those below < 0.6 as poor 
agreement.
Results  
Demographic Characteristics of the Participants
The final translated questionnaire was validated on 117 sub-
jects (40 patients with IBS, 35 FD, 12 FC, and 30 HS) by clinical 
diagnosis. The age of the HS and patients with IBS enrolled in the 
study were lower compared to patients with FD and FC, and the 
Bengali version 1a
(by Gastroenterologist, A)
EAR3Q English version
Bengali version 1b
(by Non GI Specialist)
Compare and adapt
Bengali version 2
(by Gastroenterologist, B)
Backward English version
(English teacher)
Bengali version 3
Validation
Figure. Outline of the process of trans-
lation validation of the Enhanced Asian 
Rome III questionnaire (EAR3Q) in 
Bengali language. GI, gastrointestinal.
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gender was comparable except between FD and IBS (Table 1). None 
of the enrolled patients was illiterate (educational status presented 
in Table 1). Monthly family income of the subjects with different 
FGIDs and HS as categorized as per Kuppuswamy’s classifica-
tion30 is shown in Table 1. Most of the subjects’ occupation was in 
the service sector (Table 1). 
Cognitive Debriefing
During the cognitive debriefing and validation study, all the 
subjects reported that the questionnaire was easily understood. 
However, most of them complained that it was too long. The me-
dian time needed to complete the questionnaire was 25 minutes 
(range, 15-45 minutes). In the 10-point Likert scale, the questions 
were scored satisfactory (score ranging from 5-10, mode 10). 
Validity and Reliability 
The sensitivity and specificity of the questionnaire to detect the 
clinical diagnosis made by the physician based on the Rome III cri-
teria were very high. The sensitivity of the questionnaire to diagnose 
IBS, FD, and HS at the initial visit and at the second visit after an 
interval of 2 weeks was 100%, whereas for FC it was 75% at the 
initial visit and 83% at the second visit. The specificity of the ques-
tionnaire to diagnose HS as healthy was 100% (Table 2). On test-
retest reliability, the questionnaire was found to be highly reliable. 
Though there was complete agreement between the initial diagnosis 
and that at the second visit for IBS, FD, and HS, this was not so 
for FC (Table 3). 
Table 1. Demographic and Clinical Parameters of Patients and Healthy Subjects Included in the Translation-validation Study
Parameters HS IBS FD FC P-value
Number of subjects 30 40 35 12
Age (median age [range], yr) 29 (18-46) 28 (18-65) 30 (18-70) 36 (18-70) NS
Gender (male) 23 (76.6%) 36 (90.0%) 22 (62.8%) 10 (83.3%) NS for all except FD vs IBS
Education
    Class I to X
    SSC/HSC
    Graduate/postgraduate
    Professionals/others
1 (3.3%)
5 (16.7%)
19 (63.3%)
5 (16.7%)
12 (30.0%)
13 (32.5%)
13 (32.5%)
2 (5.0%)
20 (57.2%)
8 (22.8%)
7 (20.0%)
0 (0.0%)
5 (41.7%)
5 (41.7%)
2 (16.7%)
0 (0.0%)
< 0.001
Occupation
    Housewife 
    Service sector
    Business
    Others
2 (6.7%)
24 (80.0%)
0 (0.0%)
4 (13.3%)
4 (10.0%)
12 (30.0%)
7 (17.5%)
17 (42.5%)
9 (25.71%)
16 (45.7%)
3 (8.6%)
7 (20.0%)
2 (16.7%)
7 (58.3%)
0 (0.0%)
3 (25.0%)
0.001
KS family income group (taka per month)
    > 22500 (KS group 1, 2)
    22499-11236 (KS group 3, 4)
    < 11235 (KS group 5-7)
14 (46.7%)
9 (30.0%)
7 (23.3%)
6 (15.0%)
16 (40.0%)
18 (45.0%)
1 (2.9%)
21 (60.0%)
13 (37.1%)
3 (25.0%)
3 (25.0%)
6 (50.0%)
< 0.001
HS, healthy subjects; IBS, irritable bowel syndrome; FD, functional dyspepsia; FC, functional constipation; NS, not significant; SSC, secondary school certificate; 
HSC, higher school certificate; KS, Kuppuswamy’s. 
1 US dollar = 80 taka in October 2015.
Table 2. Diagnostic Performance, Sensitivity, and Specificity of Bengali Version of Enhanced Asian Rome III Questionnaires 
Diagnostic category  
(healthy vs FBDs)
Concordance between clinical and  
questionnaire-based diagnosis on initial visit
Sensitivity Specificity
Healthy control (n = 30) 30 100% 100%
IBS (n = 40) 40 100% 100%
FD (n = 35) 35 100% 100%
FC (n = 12) 9 75% 100%
FBDs, functional bowel diseases; IBS, irritable bowel syndrome; FD, functional dyspepsia; FC, functional constipation.
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Overlap
The questionnaire detected considerable overlap between IBS 
with FD, FD with IBS or FC, FC with FD, both at the initial and 
follow-up visits, which was overlooked by the clinicians. About 20-
30% of patients with IBS had FD or FD patients had either IBS or 
FC. Frequency of overlap between IBS, FD, and FC are shown in 
Table 4. 
Discussion  
In this study, EAR3Q,14 developed by a group of Asian experts 
with an aim to overcome some of the linguistic and cultural limita-
tions of the original Rome questionnaire to diagnose FGIDs in Asia 
has been translated and validated in Bengali as per guideline by the 
Rome Foundation.29 The questionnaire was easily understood by 
the volunteers, had high sensitivity and specificity to diagnose vari-
ous FGIDs, and had excellent test-retest reliability.
In EAR3Q, though all the original R3DQ questionnaires 
were retained, some culturally adapted questions were added after 
the original Rome III questions for which understanding by Asian 
patients was thought to be difficult. Moreover, new questions have 
been developed for symptoms where it was considered that existing 
questions were inadequate for describing Asian patients’ and clini-
cians’ perspective. In the earlier study, though the Hindi, Telugu, 
and Thai questionnaires were quite sensitive and specific, the Ko-
rean and Indonesian questionnaires were not.14 The current study 
showed that the Bengali questionnaire was highly sensitive and 
specific to diagnose FGIDs. In Bengali language the term abdomi-
nal fullness, distension, and discomfort carry very close meanings 
and it is very difficult to distinguish between these terms in Bengali. 
Certain terms such as retching, bloating, incontinence, flatulence, 
mushy stool, anal blockage, and digital maneuver were difficult to 
translate into Bengali as popular and widely used terms for these 
words were difficult to find out. 
One of the striking features of our study is that the Bengali 
questionnaire detected considerable overlap between various catego-
ries of FGIDs. Such overlap has also been found in Hindi, Telugu, 
Chinese, and Korean validation studies.14 There are several possible 
reasons for this. Firstly, overlaps between various FGIDs are com-
mon in the Asian community.20,31,32 Secondly, in clinical practice 
the physician may focus on predominant symptoms and may not 
inquire into all the symptoms of FGIDs. For example, physicians 
may focus on upper GI symptoms once they diagnose FD and may 
not routinely inquire about bowel habits. Thirdly, as patients with 
overlap of both upper and lower GI symptoms are not categorized 
as a distinct disorder by the current classification of FGIDs, physi-
cians may not direct adequate attention to recognize such conditions 
Table 3. Diagnostic Performance, Test-retest Reliability of Bengali Version of Enhanced Asian Rome III Questionnaires 
Diagnostic category  
(healthy vs FBDs)
Concordance between clinical and  
questionnaire-based diagnosis  
on initial visit
Concordance between clinical and  
questionnaire-based diagnosis  
on 14th day visit
Kappa values (EAR3Q based  
diagnosis at initial and  
2-week follow-up)
Healthy control (n = 30) 30 30 1.00
IBS (n = 40) 40 40 1.00
FD (n = 35) 35 35 1.00
FC (n = 12) 9 10 0.83
FBDs, functional bowel diseases; EAR3Q, Enhanced Asian Rome III questionnaire; IBS, irritable bowel syndrome; FD, functional dyspepsia; FC, functional con-
stipation.
Table 4. Overlap Between Different Functional Bowel Diseases Detected by Bengali Version of Enhanced Asian Rome III Questionnaires During 
Validation Study
Diagnostic category
First visit Second visit at 2 weeks
Concomitant FBD (overlap) n (%) Concomitant FBD (overlap) n (%)
IBS (n = 40) FD 12 (30.0%) FD 12 (30.0%)
FD (n = 35) IBS  8 (22.8%) IBS  10 (28.5%)
FC  3 (8.5%) FC  1 (2.9%)
FC (n = 12) FD  1 (11.1%) FD  2 (20.0%)
FBD, functional bowel disease; IBS, irritable bowel syndrome; FD, functional dyspepsia; FC, functional constipation.
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in their busy clinics. This may result in inadequate treatment, in-
complete improvement, and dissatisfaction of the patients. This has 
also been found in our earlier validation study.14
Overlap between FD and IBS has been reported to be com-
mon in Asia.20,31,32 In a recent community-based survey among 
3000 Bengali speaking rural and urban population selected by 
cluster sampling in a district of Bangladesh, 42% of FD subjects 
had IBS and 27% IBS subjects had FD.20 In a multivariate logistic 
regression analysis, early satiety and epigastric pain were found to 
be the independent risk factors for FD-IBS overlap.20 In a study 
from Taiwan, among the patients diagnosed as FD after upper GI 
endoscopy, half were found to have IBS on detailed questioning.32 
As upper GI symptoms are common among IBS patients in 
Asia, patients may be diagnosed as FD and the associated IBS 
symptoms might be overlooked.7,33 Two rural and urban popula-
tion-based studies in Bangladesh using the Rome I and Rome II 
criteria demonstrated that more than 50% patients with IBS had 
upper abdominal symptoms.18,19 Similarly, in a pan-Indian study, 
49% of IBS subjects had epigastric pain.34 For psychosocial and 
socio-cultural reasons, patients may be more concerned about upper 
GI symptoms rather than their bowel habits in Asia. 
The translated questionnaire failed to pick-up diagnosis made 
by the physicians in a proportion of patients. This may result, as 
stated in other validation studies in Asia,14 from the discrepancy 
of perception about constipation by the physician and the patients. 
The patients often mean constipation to be hardness of stool and/
or sense of incomplete evacuation, whereas physicians may give 
more importance to infrequent passage of stool. In the West, bowel 
frequency between 3/week to 3/day is considered normal. In a pan-
Indian study, 99% of the Indian population had stool frequency at 
least once a day. Among patients with IBS, median stool frequency 
was twice a day irrespective of whether they had a diarrhea or con-
stipation predominant disorder.34 Only about one third of subjects 
with constipation had stool frequency less than 3 times a week.34 
In another study from South Korea, only 27% of constipation pre-
dominant IBS subjects had Bristol stool type 1 and 2.35 The shorter 
colonic transit time in the Asian population compared to the West-
ern population is well known.7 These physiologic and socio-cultural 
differences may be the cause of some discordance observed in our 
validation study.
High sensitivity and specificity of the Bengali translated ques-
tionnaire to detect the FGIDs diagnosed clinically based on Rome 
III criteria is strikingly similar to the results of translation-validation 
study of EAR3Q in Hindi, Telugu, and Chinese languages.14 But 
our findings are different from the translation-validation study in 
Korean, Indonesian, and Thai languages, in which the sensitivity 
varied between 30% and 93%, and the specificity between 90% and 
93%.14 In the test-retest reliability assessment, excellent agreement 
in the present study is also similar to the Hindi, Telugu, and Chi-
nese translation-validation study.14 
Culture may influence the beliefs and perception about health 
and disease, symptoms expression, and illness behavior includ-
ing the assumption of sick role.9-11 We believe that the cultur-
ally adapted, translated, and validated Bengali questionnaire has 
wide applicability. For example, this questionnaire may be useful 
for cross-cultural, multi-national epidemiologic, therapeutic and 
pathophysiological studies. The importance of multi-national cross-
cultural research has been increasingly recognized in the recent 
years.9-11 Moreover, physicians can use this questionnaire in clinical 
practice. This will help them to recognize overlap conditions that 
may have important implications in treatment and prognosis.7 More 
importantly, using this validated questionnaire in clinical practice 
may avoid unnecessary investigations in many patients. Thus, this 
questionnaire has potential application in health care practice con-
sidering the high burden of FGIDs in clinical practice and com-
munity.
One of the limitations of our study is that the questionnaire was 
applied in selected, educated subjects. There are minor differences 
in Bengali language between the West Bengal and Bangladesh; con-
sidering this, persons from both Bangladesh and West Bengal were 
involved during translation. This validation study was carried out 
in 2 urban centers. Although some of the included patients came to 
the capital city from different rural areas of Bangladesh, most of the 
included patients were from the urban and sub-urban areas. The 
small sample size in the validation study, particularly the number of 
FC patients may be a limitation. Lower sensitivity and reliability for 
FC compared to IBS and FD may result from the small number 
of FC patients in the study. Although the enrolled subjects filled 
up the questionnaire by themselves, a research assistant sat with the 
subjects while they filled in the questionnaire for any clarification, if 
needed. This may be a limitation, as the questionnaire is supposed 
to be self-administered. However, no patient needed any help. The 
research assistant recorded the time to complete the questionnaire. 
For measuring test-retest reliability, questionnaire was applied at 
2-week intervals that may be short and may be prone to recall bias. 
In conclusion, we successfully translated and validated the 
EAR3Q in Bengali. We believe that this translated questionnaire 
will be useful for clinical evaluation and research among the Bengali 
speaking population.
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Note: To access the supplementary Table mentioned in this 
article, visit the online version of Journal of Neurogastroenterology 
and Motility at http://www.jnmjournal.org/, and at http://dx.doi.
org/10.5056/jnm15129.
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